Hammarstrom
Jonas Hammarström, Linkoping SE
Patent application number | Description | Published |
---|---|---|
20140029803 | Knee Airbag Module - A driver assistance system ( | 01-30-2014 |
20140078291 | Driver Assisting System and Method for a Motor Vehicle - A driver assisting system ( | 03-20-2014 |
Lars Hammarstrom, Djursholm SE
Patent application number | Description | Published |
---|---|---|
20100234298 | MATRIX PROTEIN COMPOSITIONS FOR INDUCTION OF APOPTOSIS - Enamel matrix, enamel matrix derivatives and/or enamel matrix proteins or peptides may be used as therapeutic or prophylactic agents for inducing programmed cell death (apoptosis), in particular in the treatment or prevention of cancer or malignant or benign neoplasms. | 09-16-2010 |
Lars-Göran Lennart Hammarström, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20090226418 | Food Products Comprising Probiotic Micro-Organisms and Antibodies - The present invention relates to food products or pharmaceutical preparations comprising antibodies or antibody fragments which are active in the gut and probiotic micro-organisms independent from the antibodies or antibody fragments. In particular, the invention relates to a method for preparing food products and pharmaceutical preparations comprising the antibodies or antibody fragments and probiotic micro-organisms and the use of these products to deliver health benefits to humans. | 09-10-2009 |
20110123546 | Compositions Comprising Antibodies or Antibody Fragments - The present invention relates to food products or pharmaceutical preparations comprising a synergistic combination of at least two different antibodies or antibody fragments which are directed against a virus, preferably against rotavirus. | 05-26-2011 |
Lars-Göran Lennart Hammarström, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20080206233 | Heavy Chain And Single Domain Antibodies - The present invention relates to heavy chain immunoglobulins or fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof, suitable for use in the management of infections, in particular of the gastrointestinal tract. The present invention also relates to a delivery system comprising these heavy chain immunoglobulins or functional fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof, and hosts comprising expression vectors encoding for these heavy chain immunoglobulins or functional fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof. The invention also relates to food products and pharmaceutical preparations comprising the delivery system, and methods for the preparation of food products according to the invention. | 08-28-2008 |
20090226418 | Food Products Comprising Probiotic Micro-Organisms and Antibodies - The present invention relates to food products or pharmaceutical preparations comprising antibodies or antibody fragments which are active in the gut and probiotic micro-organisms independent from the antibodies or antibody fragments. In particular, the invention relates to a method for preparing food products and pharmaceutical preparations comprising the antibodies or antibody fragments and probiotic micro-organisms and the use of these products to deliver health benefits to humans. | 09-10-2009 |
Lars-Göran Lennart Hammarström US
Patent application number | Description | Published |
---|---|---|
20120141503 | Heavy Chain and Domain Antibodies - The present invention related to heavy chain immunoglobulins or fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof, suitable for use in the management of infections, in particular gastrointestinal tract. The present invention also relates to a delivery system comprising these heavy chain immunoglobulins or functional fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof, and hosts comprising expression vectors encoding for these heavy chain immunoglobulins or functional fragments thereof of the VHH or VNAR type, or domain antibodies (dAbs) of the heavy or light chains of immunoglobulins or fragments thereof. The invention also related to food products and pharmaceutical preparations comprising the delivery system, and method for the preparation of food products according to the invention. | 06-07-2012 |
Lennart Hammarstrom, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20080213224 | Immunoglobulin against helicobacter pylori - The present invention relates to materials and methods for prevention, treatment and diagnosing of infections caused by | 09-04-2008 |
20100119553 | Helicobacter pylori sialic acid binding adhesin, SabA and sabA - gene - An isolated | 05-13-2010 |
20130323819 | EXPRESSION OF ANTIBODY OR A FRAGMENT THEREOF IN LACTOBACILLUS - Described herein are methods and compositions for expressing an antibody or a fragment thereof in a microorganism and use of the microorganism to treat or prevent a pathogenic infection in a mammal. | 12-05-2013 |
Lennart Hammarström, Huddinge SE
Patent application number | Description | Published |
---|---|---|
20110311475 | MEANS AND METHOD FOR THE TREATMENT OF ANTIBODY DEFICIENCY DISEASES BASED ON IL-21 AND IL-21 VARIANTS - The present invention relates to an lnterleukin-21 (IL-21) variant which is capable of increasing the secretion of IgG and/or IgA antibodies in B cells and/or is capable of binding the IL-2 receptor complex and/or the IL-4 receptor complex, comprising stretches of amino acids of lnterleukin-4 (IL-4) or lnterleukin-2 (IL-2) in substitution of amino acids of IL-21. The present invention also relates to a pharmaceutical composition comprising IL-21 and/or an IL-21 variant and at least one compound selected from IgA inducing protein (IGIP), Syntenin-1, Galectin-1 and Galectin-3. The present invention further relates to a pharmaceutical composition for the treatment of a primary humoral immunodeficiency disease comprising IL-21 and/or an IL-21 variant and IL-4 and/or IL-2 and/or IGIP and/or Syntenin-1 and/or Galectin-1 and/or Galectin-3. Furthermore the present invention relates to a kit for the treatment of a primary humoral immunodeficiency disease, comprising IL-21 and/or an IL-21 variant and IL-4 and/or IL-2 and/or IGIP and/or Syntenin-1 and/or Galectin-1 and/or Galectin-3 and optionally at least one element selected from a stimulator of CD40 molecules, a ligand of the tumor necrosis superfamily, a polypeptide with human leukocyte interferon activity, a vaccine protein antigen; and a vaccine polysaccharide antigen. | 12-22-2011 |
Ola Hammarstrom, Lerdala SE
Patent application number | Description | Published |
---|---|---|
20090118643 | Sensor and Guide Wire Assembly - The invention relates to a sensor and guide wire assembly ( | 05-07-2009 |
Per Hammarstrom, Linkoping SE
Patent application number | Description | Published |
---|---|---|
20090197343 | METHODS FOR DETECTION OF PATHOGENIC PRION PROTEINS ASSOCIATED WITH PRION DISEASES, USING CONJUGATED POLYELECTROLYTES - The present invention relates to a method for detecting the presence of a pathogenic prion species in a sample comprising the steps—bringing the sample in contact with at least one conjugated polyelectrolyte (CPE)—irradiating the CPE with electromagnetic radiation—measuring the radiation emitted or absorbed by the CPE at at least one wavelength, and—comparing the measured emitted or absorbed radiation to at least one reference value corresponding to the CPE interacting with a known prion species. Optionally, the emitted or absorbed radiation is measured at least two wavelengths and a ratio is formed of the values of the measured radiation. The method facilitates differentiation between different strains of pathogenic prion species. The invention also relates to devices for performing the method. | 08-06-2009 |
Per, Jonas Hammarström, Linkoping SE
Patent application number | Description | Published |
---|---|---|
20110311103 | METHOD AND SYSTEM OF AUTOMATICALLY DETECTING OBJECTS IN FRONT OF A MOTOR VEHICLE - A method of automatically detecting objects in front of a motor vehicle comprises the steps of pre-storing template objects representing possible objects in front of the motor vehicle, detecting images from a region in front of the vehicle by a vehicle mounted imaging means, generating a processed image containing disparity or vehicle-to-scene distance information from the detected images, comparing the pre-stored template objects with corresponding regions-of-interest of the processed image, and generating a match result relating to the match between the processed image and the template objects. Each of the pre-stored template objects is a flat two-dimensional multi-pixel area of predetermined shape. | 12-22-2011 |
20120026332 | Vision Method and System for Automatically Detecting Objects in Front of a Motor Vehicle - A vision method for automatically detecting objects in front of a motor vehicle, comprises the steps of detecting images from a region in front of the vehicle by a vehicle mounted imaging means; generating from said detected images a processed image, containing disparity or vehicle-to-scene distance information; comparing regions-of-interest of said processed image to template objects relating to possible objects in front of the motor vehicle; calculating for each template object a score relating to the match between said processed image and the template object; and identifying large scores of sufficient absolute magnitude of said calculated scores. The vision method further comprises the steps of applying an algorithm adapted to identify groups of said large scores, and assigning an identified group of large scores to a single match object. | 02-02-2012 |